Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

摘要

During these last two years less drug regimens (LDRs) in HIV, and in particular protease inhibitor (PI)/r-basedudstrategies, have been explored both in clinical trials and in clinical practice. Many results are now available andudmore is known about how to use them safely and effectively. Understanding that an LDR strategy represents a realudtailored therapeutic approach for the patient is crucial for the long-term success and positive management of HIVudinfection. Trust between patients and HIV specialists and a real focus on the patient’s life are key factors for longudlife treatment success, in particular when using a LDR strategy. This is clearly shown by the HIV patient’s journeyud(HPJ) methodology, used in an Italian national workshop to better define the criteria and challenges of LDR strategies.udThis paper shows the results of this complex process.